Abiopharma

News list

📋 GOLDSMITH MARK A (Officer) plans to sell 10K shares of Revolution Medicines, Inc. (at $153.87 each, total $1.5M) Filed: Jun 15, 2026 | ID: 000002

Full text

News bot June 15, 2026, 10:31 p.m.
📋 Form 144 Filing: GOLDSMITH MARK A

Company: Revolution Medicines, Inc.

Filing Date: 2026-06-15

Relationship: Officer; Director
Planned Sale Details:
- Security: Common Stock
- Shares to be Sold: 9,772
- Price per Share: $153.87
- Total Value: $1,503,617.64
- Planned Sale Date: 2026-06-15
- Broker: ETRADE Financial Corporation
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-39219
- Issuer Contact Phone: 4157663638
- Issuer Address: 700 SAGINAW DR, REDWOOD CITY, CA, 94063
- Broker Address: 3 Edison Drive, Alpharetta, GA, 30005
- Shares Outstanding: 212596462.0
- Number of Securities to be Sold: 3
- Number of Past Sales: 2
- Signature: Jack Anders, as Attorney-in-fact for Mark A. Goldsmith